50609-01-3
[1]Patent:WO2007/53452,2007,A1.Locationinpatent:Page/Pagecolumn120
[2]Patent:WO2012/60847,2012,A1.Locationinpatent:Page/Pagecolumn43-44
14394-70-8
[1]Patent:WO2012/60847,2012,A1
[1]CurrentPatentAssignee:SUNYAT-SENUNIVERSITY(CHINA)-CN112110863,2020,A
[1]CurrentPatentAssignee:SUNYAT-SENUNIVERSITY(CHINA)-CN112110863,2020,A
[2]Wei,Mingjie;Liang,Dacheng;Cao,Xiaohui;Luo,Wenjun;Ma,Guojian;Liu,Zeyuan;Li,Le[AngewandteChemie-InternationalEdition,2021,vol.60,#13,p.7397-7404][Angew.Chem.,2021,vol.133,#13,p.7473-7480,8]
[1]CurrentPatentAssignee:SUNYAT-SENUNIVERSITY(CHINA)-CN112110863,2020,ALocationinpatent:Paragraph0167-0172
[2]Wei,Mingjie;Liang,Dacheng;Cao,Xiaohui;Luo,Wenjun;Ma,Guojian;Liu,Zeyuan;Li,Le[AngewandteChemie-InternationalEdition,2021,vol.60,#13,p.7397-7404][Angew.Chem.,2021,vol.133,#13,p.7473-7480,8]
Title: Differences in gene expression and alterations in cell cycle of acute myeloid leukemia cell lines after treatment with JAK inhibitors.
Journal: European journal of pharmacology 20151015
Title: Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20150601
Title: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Journal: Nature chemical biology 20140401
Title: Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
Journal: The Biochemical journal 20130901
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms.
Journal: Molecular diagnosis & therapy 20121001
Title: JAK2 inhibitors and their impact in myeloproliferative neoplasms.
Journal: Hematology (Amsterdam, Netherlands) 20120401
Title: New generation small-molecule inhibitors in myeloproliferative neoplasms.
Journal: Current opinion in hematology 20120301
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: Targeting myeloproliferative neoplasms with JAK inhibitors.
Journal: Current opinion in hematology 20110301
Title: JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.
Journal: Leukemia 20110201
Title: Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.
Journal: PloS one 20110101
Title: Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3.
Journal: Bioorganic & medicinal chemistry letters 20101215
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: Inhibition of JAK-STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells.
Journal: Leukemia 20100701
Title: Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.
Journal: Cancer cell 20100615
Title: Therapeutic potential of JAK2 inhibitors.
Journal: Hematology. American Society of Hematology. Education Program 20090101
Title: TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.
Journal: Leukemia 20080901
Title: Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
Journal: Cancer cell 20080401
Title: Wernig G, et al. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera. Cancer Cell. 2008 Apr;13(4):311-20.
Title: Geron I, et al. Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors. Cancer Cell. 2008 Apr;13(4):321-30.
